Skip to content

EFFICACY OF VIRECHANA KARMA AND SHAMANA SNEHAPANA WITH TRIPHALADI TAILA IN THE MANAGEMENT OF STHAULYA (OBESITY)

EFFICACY OF VIRECHANA KARMA AND SHAMANA SNEHAPANA WITH TRIPHALADI TAILA IN THE MANAGEMENT OF STHAULYA (OBESITY):AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042072
Enrollment
20
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Government Akhandanand Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 18 to 60 years with classical signs and symptoms of Sthaulya. Patients having BMI (Body Mass Index) greater than and equal to 25 and less than and equal to 35 will be taken for the study. Virechana Yogya and Snehana Yogya as per Ayurvedic Classics will be included.

Exclusion criteria

Exclusion criteria: Patients having age less than 18 and greater than 60 will be excluded. Known case of serious Cardiac, Renal or Hepatic diseases, AIDS, STD, TB, uncontrolled DM, Hypertension. Obesity due to drugs e.g.,Anticonvulsant, Antipsychotics, Beta-blockers, long term use of steroids. Pregnant and lactating women. BMI less than 25 and greater than 35 will be excluded. Virechana Ayogya and Snehana Ayogya patients as per Ayurvedic Classics will be excluded.

Design outcomes

Primary

MeasureTime frame
To reduce weight gain (obesity) in the patients.Timepoint: 21 days

Secondary

MeasureTime frame
To improve quality of life of obesity patients.Timepoint: 35 days

Countries

India

Contacts

Public ContactFalgun Patel

Government Akhandanand Ayurved College

vd.falgun@gmail.com9426404004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026